Do analysts recommend SISI or SXTPW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 60 Degrees Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, SISI or SXTPW?

60 Degrees Pharmaceuticals has lower revenue, but higher earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shineco $9.60M 0.00 -$22.45M -$204.00 N/A 60 Degrees Pharmaceuticals $1.11M N/A N/A N/A N/A

Do analysts recommend BFRIW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biofrontera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, BFRIW or SISI?

Biofrontera has higher revenue and earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $46.18M N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Do analysts rate CINGW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cingulate 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, CINGW or SISI?

Cingulate has higher earnings, but lower revenue than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cingulate N/A N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Is CINGW or SISI more profitable?

Cingulate has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Cingulate's return on equity of 0.00% beat Shineco's return on equity. Company Net Margins Return on Equity Return on Assets Cingulate N/A N/A N/A Shineco -380.55% -79.89% -33.01%

Do analysts prefer CLVR or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clever Leaves 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, CLVR or SISI?

Clever Leaves has higher revenue and earnings than Shineco. Clever Leaves is trading at a lower price-to-earnings ratio than Shineco, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clever Leaves $17.42M 0.00 -$17.90M -$9.66 N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Do analysts rate SISI or CMRAW?

Given Comera Life Sciences' higher probable upside, analysts clearly believe Comera Life Sciences is more favorable than Shineco. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Comera Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, SISI or CMRAW?

Comera Life Sciences has lower revenue, but higher earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shineco $9.60M 0.00 -$22.45M -$204.00 N/A Comera Life Sciences $1.00M N/A N/A N/A N/A

Shineco (SISI) Competitors

$0.10 0.00 (0.00%)

As of 09/23/2026

Compare

SISI vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Shineco stock or one of its competitors? Shineco's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Shineco compare to 60 Degrees Pharmaceuticals?

Shineco (NASDAQ:SISI) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

60 Degrees Pharmaceuticals has a net margin of 0.00% compared to Shineco's net margin of -380.55%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
60 Degrees Pharmaceuticals	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
60 Degrees Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Shineco. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Shineco. Shineco's average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Shineco	Neutral
60 Degrees Pharmaceuticals	Neutral

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

60 Degrees Pharmaceuticals has lower revenue, but higher earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A
60 Degrees Pharmaceuticals	$1.11M	N/A	N/A	N/A	N/A

Summary

Shineco and 60 Degrees Pharmaceuticals tied by winning 4 of the 8 factors compared between the two stocks.

How does Shineco compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Biofrontera has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Biofrontera's return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Biofrontera	Neutral
Shineco	Neutral

4.1% of Shineco shares are held by institutional investors. 0.0% of Shineco shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biofrontera	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biofrontera has higher revenue and earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$46.18M	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

Summary

Biofrontera beats Shineco on 4 of the 7 factors compared between the two stocks.

How does Shineco compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cingulate	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cingulate has higher earnings, but lower revenue than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cingulate	N/A	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

4.1% of Shineco shares are held by institutional investors. 0.0% of Shineco shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cingulate has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Cingulate's return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cingulate	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Cingulate	Neutral
Shineco	Neutral

Summary

Shineco beats Cingulate on 4 of the 7 factors compared between the two stocks.

How does Shineco compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Shineco (NASDAQ:SISI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

Clever Leaves has higher revenue and earnings than Shineco. Clever Leaves is trading at a lower price-to-earnings ratio than Shineco, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clever Leaves	$17.42M	0.00	-$17.90M	-$9.66	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

6.9% of Clever Leaves shares are owned by institutional investors. Comparatively, 4.1% of Shineco shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by insiders. Comparatively, 0.0% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Clever Leaves has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Clever Leaves' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clever Leaves	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

Clever Leaves has a beta of 3853.65, indicating that its stock price is 385,265% more volatile than the broader market. Comparatively, Shineco has a beta of -1.76, indicating that its stock price is 276% less volatile than the broader market.

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Clever Leaves	Neutral
Shineco	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clever Leaves	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Clever Leaves beats Shineco on 9 of the 12 factors compared between the two stocks.

How does Shineco compare to Comera Life Sciences?

Shineco (NASDAQ:SISI) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

In the previous week, Shineco's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company	Overall Sentiment
Shineco	Neutral
Comera Life Sciences	Neutral

Comera Life Sciences has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Comera Life Sciences' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
Comera Life Sciences	N/A	N/A	N/A

Given Comera Life Sciences' higher probable upside, analysts clearly believe Comera Life Sciences is more favorable than Shineco.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Comera Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Comera Life Sciences has lower revenue, but higher earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A
Comera Life Sciences	$1.00M	N/A	N/A	N/A	N/A

Summary

Shineco and Comera Life Sciences tied by winning 4 of the 8 factors compared between the two stocks.

Get Shineco News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SISI vs. The Competition

Export

Metric	Shineco	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$44K	$12.50B	$7.26B	$13.10B
Dividend Yield	N/A	2.63%	2.52%	12.57%
P/E Ratio	0.00	792.39	274.69	25.75
Price / Sales	0.00	850.84	679.25	97.61
Price / Cash	N/A	88.64	77.80	52.76
Price / Book	0.00	10.69	10.52	6.34
Net Income	-$22.45M	$2.83B	$3.49B	$360.00M
7 Day Performance	N/A	-0.69%	-1.08%	-0.10%
1 Month Performance	N/A	-1.10%	-3.39%	-3.41%
1 Year Performance	-98.36%	2.10%	15.08%	5.46%

Shineco Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SISI Shineco	N/A	$0.11 flat	N/A	-98.4%	$44K	$9.60M	N/A	119
SXTPW 60 Degrees Pharmaceuticals	N/A	$0.04 flat	N/A	-25.4%	$0.00	$1.11M	N/A	2
BFRIW Biofrontera	N/A	$0.02 flat	N/A	-80.2%	$0.00	$46.18M	N/A	70
CINGW Cingulate	N/A	$0.01 flat	N/A	-85.3%	$0.00	N/A	N/A	20	Positive News
CLVR Clever Leaves	N/A	$0.00 flat	N/A	-50.0%	$0.00	$17.42M	N/A	560

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SISI) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shineco (SISI) Competitors

SISI vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

How does Shineco compare to 60 Degrees Pharmaceuticals?

Summary

How does Shineco compare to Biofrontera?

Summary

How does Shineco compare to Cingulate?

Summary

How does Shineco compare to Clever Leaves?

Summary

How does Shineco compare to Comera Life Sciences?

Summary

Media Sentiment Over Time

SISI vs. The Competition

Shineco Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shineco (SISI) Competitors

SISI vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

How does Shineco compare to 60 Degrees Pharmaceuticals?

Is SISI or SXTPW more profitable?

Do analysts recommend SISI or SXTPW?

Does the media refer more to SISI or SXTPW?

Do institutionals & insiders have more ownership in SISI or SXTPW?

Which has better valuation & earnings, SISI or SXTPW?

Summary

How does Shineco compare to Biofrontera?

Is BFRIW or SISI more profitable?

Does the media prefer BFRIW or SISI?

Do institutionals & insiders have more ownership in BFRIW or SISI?

Do analysts recommend BFRIW or SISI?

Which has higher valuation and earnings, BFRIW or SISI?

Summary

How does Shineco compare to Cingulate?

Do analysts rate CINGW or SISI?

Which has higher earnings & valuation, CINGW or SISI?

Do insiders and institutionals hold more shares of CINGW or SISI?

Is CINGW or SISI more profitable?

Does the media favor CINGW or SISI?

Summary

How does Shineco compare to Clever Leaves?

Which has better earnings & valuation, CLVR or SISI?

Do institutionals & insiders believe in CLVR or SISI?

Is CLVR or SISI more profitable?

Which has more risk & volatility, CLVR or SISI?

Does the media refer more to CLVR or SISI?

Do analysts prefer CLVR or SISI?

Summary

How does Shineco compare to Comera Life Sciences?

Does the media refer more to SISI or CMRAW?

Is SISI or CMRAW more profitable?

Do analysts rate SISI or CMRAW?

Do insiders and institutionals hold more shares of SISI or CMRAW?

Which has higher valuation and earnings, SISI or CMRAW?

Summary

Media Sentiment Over Time

SISI vs. The Competition

Shineco Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools